From: Cystathionine-β-Synthase Inhibition for Colon Cancer: Enhancement of the Efficacy of Aminooxyacetic Acid via the Prodrug Approach
Compound
Structure
CBS activity (% of control) at 100 µmol/L
AOAA
10 ± 3
YD0135
114 ± 5
YD0151
91 ± 2
YD0154
74 ± 5
YD0163
163 ± 12
YD0164
83 ± 9
YD0177
92 ± 3
YD0196
108 ± 11
YD0197
94 ± 3